With approximately 10 approved products and several under development, the Herceptin® biosimilars market is projected to witness considerable growth over the coming years, claims Roots Analysis

Herceptin® sales peaked in 2018, a year before the primary patent covering the drug expired in the US; in order to carve out a share of the associated opportunity, stakeholders in the pharma industry have long been developing follow on products

For additional details, please visit
https://www.rootsanalysis.com/reports/biopharmaceutical-cros-market.html
With approximately 10 approved products and several under development, the Herceptin® biosimilars market is projected to witness considerable growth over the coming years, claims Roots Analysis Herceptin® sales peaked in 2018, a year before the primary patent covering the drug expired in the US; in order to carve out a share of the associated opportunity, stakeholders in the pharma industry have long been developing follow on products For additional details, please visit https://www.rootsanalysis.com/reports/biopharmaceutical-cros-market.html
WWW.ROOTSANALYSIS.COM
Biopharmaceutical Contract Research Organization Market 2021-2030 | Industry Analysis | Market Size | 2030
Biopharmaceutical Contract Research Organization Market report features an extensive study of the current market landscape and future potential of the industry
0 Comments 0 Shares